Pinnacle Hill is a groundbreaking partnership between the University of North Carolina at Chapel Hill and Deerfield Management, with the shared goal of revolutionizing drug research and development. This innovative company aims to address the pressing medical needs of our time by discovering new medicines across a wide range of therapeutic areas. With an impressive investment of up to $65 million and the invaluable expertise of Deerfield, Pinnacle Hill will propel promising therapeutic research at UNC-Chapel Hill.

Every drug research project undertaken by Pinnacle Hill is carefully selected and approved by a joint steering committee composed of members from both UNC-Chapel Hill and Deerfield leadership teams. Pinnacle Hill ensures that each selected project receives sufficient funding to support investigational new drug enabling studies. This commitment allows for the advancement of groundbreaking drug research and the potential to transform patients' lives.

Deerfield, an investment management firm, is deeply devoted to advancing healthcare through investment, information, and philanthropy. To learn more about Pinnacle Hill, please visit their official website at www. deerfield.

com. For information about the University of North Carolina at Chapel Hill, the first public university in the nation known for its innovative teaching, research, and public service, visit www. unc.

edu